Solute Carrier Family 22 Member 31 (SLC22A31) was identified as one of the prognostic genes in right-sided colon cancer (Liang et al., 2018), which warrants exploration of its significance in other cancer types as well, including the breast cancer. This evidence concerns the gene SLC22A31 and breast cancer.